Home Search Abstracts View Session E-mail Abstract Author


Session 39 Oral Abstracts
Hepatitis B and C: Epidemiology, Pathogenesis, and Treatment
Session Day and Time: Wednesday, 10 - 11:45 am
Presentation Time: 10:00 am
Room: Room 515


130
Acute Hepatitis C in Men Who Have Sex With Men Is Not Confined to Those Infected with HIV, and Their Number Continues to Increase
Martin Fisher*1, D Richardson1, and C Sabin2
1Royal Sussex County Hosp, Brighton, UK and 2Royal Free and Univ Coll London Med Sch, UK

Background:  Transmission of hepatitis C (HCV) among cohorts of HIV-infected men who have sex with men (MSM) have been increasingly reported over the past few years, possibly resulting from high-risk sexual practices. Since acute HCV is usually asymptomatic, diagnoses are generally made by routine HCV antibody (HCV-ab) screening or by investigating significant transaminase rises. Since HIV MSM do not routinely undergo HCV-ab screening, it is unclear whether there has been a similar increase in acute HCV in this group.

Methods:  Subjects were MSM attending a single HIV/STD center between 2000 and 2006. Subjects were included if they had had at least 2 HCV-ab tests during the study period, of which the first was negative. If any subsequent test was HCV+, the time of acquisition was attributed as the time of the positive test. Subjects were classified as HIV+, HIV, or untested.

Results:  During the study period, 7223 MSM were seen, of whom 34 individuals were diagnosed with acute HCV; 10 were HIV+, 6 HIV, and 10 HIV-untested. The seroconversion rates in the HIV group was 41.6/100 person-years (95%CI 15.3 to 90.5); HIV+ group 53.0/100 person-years (25.4 to 97.5); HIV unknown 38.2/100 person-years (18.3 to 70.3).  Although the rate was higher in the HIV+ group, this is not statistically significant (relative rate RR 1.27, 0.46 to 3.51, p = 0.64). There is an increased seroconversion rate over time. The rates in 2001, 2002, 2003, 2004, and 2005 were 11.0 (0.3 to 61.4), 20.3 (4.2 to 59.4), 53.3 (24.4 to 101.3), 63.8 (29.2 to 121.2), and 86.4 (23.6 to 221.3), respectively. The relative rates (and 95%CI) for 2001, 2002, 2003, and 2004 (compared with 2005) were 0.13 (0.01 to 1.14), 0.24 (0.05 to 1.05), 0.62 (0.19 to 2.00), and 0.74 (0.23 to 2.40). Overall, the seroconversion rate increased by 59% per year (RR per year 1.59, 1.13 to 2.25, p = 0.008).

Conclusions:  There has been, and continues to be a significant increase in acute HCV in MSM. Contrary to current evidence, this phenomenon is not exclusively in MSM with HIV. This would suggest that routine HCV testing is required in all MSM presenting to sexually transmitted disease (STD)/HIV centers.